Semaglutide and Gut Hormones: Impact on Appetite Regulation
Semaglutide, a medication initially developed for the treatment of type 2 diabetes, has gained attention because of its remarkable efficacy in weight loss. This injectable medication belongs to a type of drugs called GLP-1 receptor agonists, which work by mimicking the action of a naturally occurring hormone in the body. However, its weight loss benefits were discovered during clinical trials for diabetes treatment when participants experienced significant reductions in body weight as a side effect Studies show that Semaglutide can lead to substantial weight reduction in individuals with obesity or overweight, even when comparing to other weight reduction interventions. Its mechanism of action involves multiple pathways, including reducing appetite, increasing feelings of fullness, and slowing down gastric emptying, ultimately leading to reduced food intake and calorie absorption. The potency of Semaglutide in fat loss has been demonstrated in several clinical trials, with participant